| Trial ID: | L4088 |
| Source ID: | NCT00479986
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
|
| Acronym: |
PIOcard
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Cardiovascular Disease
|
| Interventions: |
DRUG: pioglitazone|DRUG: placebo
|
| Outcome Measures: |
Primary: Short-term effect of Pioglitazone on Markers of vascular risk (MMP-9, hsCRP, monocyte activation), 4 weeks | Secondary: Safety, 4 weeks|Metabolic control (HbA1c, Glucose), 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: IKFE Institute for Clinical Research and Development | Collaborators: Takeda|Johannes Gutenberg University Mainz|Heidelberg University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
92
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-06
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-01
|
| Locations: |
Dr. Michael Morcos, Heidelberg, Germany|IKFE, Mainz, 55116, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00479986
|
